Pini, A. and Obara, I. and Battell, E. and Chazot, P.L. and Rosa, A.C. (2016) 'Histamine in diabetes : is it time to reconsider?', Pharmacological research., 111 . pp. 316-324.
The first studies of histamine and diabetes date back to the 1950s. Since that time the involvement of histamine in diabetes was related to its well known vasoactive properties and permeability leakage effects. In particular, the first evidence for a correlation between histamine and diabetes arose in 1989 when an increase in plasma and leucocyte histamine content was observed. Limited independent evidence followed in the subsequent two decades, focusing on both histamine glyceamic control and macro- and microvascular complications of diabetes. However, recent observations have sparked the question whether it is time to reconsider the functional contribution of histamine in diabetes. We reveal an interesting upsurge in the field which provides scope for new insights into the role of histamine in diabetes.
|Full text:||(AM) Accepted Manuscript|
Available under License - Creative Commons Attribution Non-commercial No Derivatives.
Download PDF (1064Kb)
|Publisher Web site:||https://doi.org/10.1016/j.phrs.2016.06.021|
|Publisher statement:||© 2016 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/|
|Date accepted:||21 June 2016|
|Date deposited:||04 July 2016|
|Date of first online publication:||22 June 2016|
|Date first made open access:||22 June 2017|
Save or Share this output
|Look up in GoogleScholar|